Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial
乔垣结衣
20天前
51
10
已完结
1. 系统已在2025-04-07 16:50:29对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.radonc.2023.109679
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0167814023002177
其他信息:
出版社: Elsevier BV
作者: Wensi Zhao; Shaobo Ke; Xiaojun Cai; Zhigang Zuo; Wei Shi; Hu Qiu; Gaoke Cai; Yi Gong; Yong Wu; Shasha Ruan; Yongshun Chen